(Q34165258)

31 July 2017

1 reference

title

5-HT6 receptor ligands and their antipsychotic potential (English)

1 reference

31 July 2017

5-HT6 Receptor Ligands and their Antipsychotic Potential (English)

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

24 November 2024

Jørn Arnt

1 reference

31 July 2017

Christina Kurre Olsen

series ordinal

1 reference

31 July 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21329787

24 November 2024

publication date

1 January 2011

1 reference

31 July 2017

2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21329787

International Review of Neurobiology

24 November 2024

published in

1 reference

31 July 2017

1 reference

31 July 2017

page(s)

141-161

1 reference

Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat.

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Pharmacological Specificity of Conditioned Avoidance Response Inhibition in Rats: Inhibition by Neuroleptics and Correlation to Dopamine Receptor Blockade

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats.

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Do Novel Antipsychotics Have Similar Pharmacological Characteristics? A Review of the Evidence

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist, Ro 04-6790, in rats.

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Medial frontal cortex mediates perceptual attentional set shifting in the rat.

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

A null mutation of the serotonin 6 receptor alters acute responses to ethanol

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Involvement of 5-HT6 receptors in nigro-striatal function in rodents

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Reversal of cognitive deficits by an ampakine (CX516) and sertindole in two animal models of schizophrenia--sub-chronic and early postnatal PCP treatment in attentional set-shifting.

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activity

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Activation of 5-HT(6) receptors facilitates attentional set shifting

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Potent antagonism of 5-HT(3) and 5-HT(6) receptors by olanzapine

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

The 5-HT(6) receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Mice mutant for genes associated with schizophrenia: common phenotype or distinct endophenotypes?

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

5-HT6 receptor binding sites in schizophrenia and following antipsychotic drug administration: autoradiographic studies with [125I]SB-258585.

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Gestational methylazoxymethanol acetate treatment impairs select cognitive functions: parallels to schizophrenia

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Increased expression of 5-HT6 receptors in the nucleus accumbens blocks the rewarding but not psychomotor activating properties of cocaine

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

The selective 5-HT6 receptor antagonists SB-271046 and SB-399885 potentiate NCAM PSA immunolabeling of dentate granule cells, but not neurogenesis, in the hippocampal formation of mature Wistar rats

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Behavioural and neurochemical effects of post-weaning social isolation in rodents-relevance to developmental neuropsychiatric disorders.

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

5-HT(6) receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Developing translational animal models for symptoms of schizophrenia or bipolar mania

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Comparison of haloperidol, risperidone, sertindole, and modafinil to reverse an attentional set-shifting impairment following subchronic PCP administration in the rat--a back translational study

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat.

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

American Journal of Psychiatry

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

5-HT6 receptor antagonists improve performance in an attentional set shifting task in rats

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A) receptor mechanisms

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and D-amphetamine in the rat.

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Modeling cognitive endophenotypes of schizophrenia in mice

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

E-6801, a 5-HT6 receptor agonist, improves recognition memory by combined modulation of cholinergic and glutamatergic neurotransmission in the rat.

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation--an effect sensitive to NMDA receptor antagonism

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Advancing a functional genomics for schizophrenia: psychopathological and cognitive phenotypes in mutants with gene disruption.

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

5‐HT6 receptor antagonist SB‐271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Effect of the 5-HT6 receptor antagonists Ro04-6790 and Ro65-7199 on latent inhibition and prepulse inhibition in the rat: comparison to clozapine

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Gestational methylazoxymethanol acetate administration: a developmental disruption model of schizophrenia

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Pro-cognitive effects of 5-HT6 receptor antagonists in the social recognition procedure in rats: implication of the frontal cortex

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

A preliminary investigation into the effects of antipsychotics on sub-chronic phencyclidine-induced deficits in attentional set-shifting in female rats

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Effect of the acute and chronic administration of the selective 5-HT6 receptor antagonist SB-271046 on the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

5-HT6 receptors: a novel target for cognitive enhancement

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

5-HT6 receptor antagonist reversal of emotional learning and prepulse inhibition deficits induced by apomorphine or scopolamine.

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Mice with reduced NMDA receptor expression display behaviors related to schizophrenia

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Effect of sertindole on extracellular dopamine, acetylcholine, and glutamate in the medial prefrontal cortex of conscious rats: a comparison with risperidone and exploration of mechanisms involved.

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

The pharmacology of latent inhibition as an animal model of schizophrenia

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Using pharmacokinetic-pharmacodynamic modelling as a tool for prediction of therapeutic effective plasma levels of antipsychotics

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Decrease in parvalbumin-expressing neurons in the hippocampus and increased phencyclidine-induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

The selective 5-HT(6) receptor antagonist Ro 04-6790 attenuates psychotomimetic effects of the NMDA receptor antagonist MK-801.

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Effects of the 5-HT(6) receptor antagonist, SB-271046, in animal models for schizophrenia

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Calcium binding protein markers of GABA deficits in schizophrenia--postmortem studies and animal models

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

The distribution of 5-HT(6) receptors in rat brain: an autoradiographic binding study using the radiolabelled 5-HT(6) receptor antagonist [(125)I]SB-258585.

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Reversal of subchronic PCP-induced deficits in attentional set shifting in rats by sertindole and a 5-HT6 receptor antagonist: comparison among antipsychotics.

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Effects of the novel 5-HT(6) receptor antagonist RO4368554 in rat models for cognition and sensorimotor gating

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurones in rats: acute and repeated treatment

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Differential effect of antipsychotics on place navigation of rats in the Morris water maze. A comparative study between novel and reference antipsychotics.

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Efficacy of antipsychotics to reverse phencyclidine-induced social interaction deficits in female rats--a preliminary investigation

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Improvement of phencyclidine-induced social behaviour deficits in rats: involvement of 5-HT1A receptors

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Postnatal phencyclidine administration selectively reduces adult cortical parvalbumin-containing interneurons

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

Colocalization of serotonin receptor subtypes 5-HT2A, 5-HT2C, and 5-HT6 with neuropeptides in rat striatum

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385902-0.00006-1

24 November 2024

Identifiers

DOI

1 reference

31 July 2017

1 reference